110 related articles for article (PubMed ID: 21040668)
1. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
Hansen PB; Al-Farra G
Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system posttransplant lymphoproliferative disease: An uncommon diagnostic dilemma.
Degen D; Kanellis J; Hughes P; Barit D; Ierino F
Nephrology (Carlton); 2016 Jun; 21(6):528. PubMed ID: 27188412
[No Abstract] [Full Text] [Related]
4. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
Ohguro N; Hashida N; Tano Y
Arch Ophthalmol; 2008 Jul; 126(7):1002-3. PubMed ID: 18625954
[No Abstract] [Full Text] [Related]
7. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
[No Abstract] [Full Text] [Related]
8. [Epstein-Barr virus-associated posttransplant lymphoproliferative disease after renal transplantation].
Matsubara E; Yakushijin Y; Nomura T; Iwamasa K; Narumi H; Sakai I; Yasukawa M; Fujita S; Hato T; Ohshima K; Uno M
Rinsho Ketsueki; 2002 Oct; 43(10):949-53. PubMed ID: 12462032
[TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA
Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091
[TBL] [Abstract][Full Text] [Related]
10. [A case of malignant lymphoma after renal transplantation].
Oyama H; Yamao K; Sugiyama T; Matsuura O; Murakami S; Ikeda K; Inoue S
No Shinkei Geka; 1997 Jul; 25(7):655-60. PubMed ID: 9218261
[TBL] [Abstract][Full Text] [Related]
11. Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.
Muzaffar M; Taj A; Ratnam S
Am J Ther; 2010; 17(6):e230-3. PubMed ID: 19918163
[TBL] [Abstract][Full Text] [Related]
12. Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft.
Tang S; Lai KN
Am J Kidney Dis; 2005 Apr; 45(4):A55, e61-2. PubMed ID: 15806458
[No Abstract] [Full Text] [Related]
13. Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
Ninan MJ; Datta YH
Am J Hematol; 2010 Aug; 85(8):635-7. PubMed ID: 20578201
[No Abstract] [Full Text] [Related]
14. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
15. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo.
Daibata M; Bandobashi K; Kuroda M; Imai S; Miyoshi I; Taguchi H
J Virol; 2005 May; 79(9):5875-9. PubMed ID: 15827204
[TBL] [Abstract][Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Case 8-2006. A 71-year-old woman with Crohn's disease and altered mental status.
Podolsky DK; Gonzalez RG; Hasserjian RP
N Engl J Med; 2006 Mar; 354(11):1178-84. PubMed ID: 16540619
[No Abstract] [Full Text] [Related]
17. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
18. [Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
Bacha MM; Abderrahim E; Ounissi M; Chaouech D; Cherif M; Turki S; Rajhi H; Znaidi N; Bahloul A; Trabelsi S; Khaled S; Ben Abdallah T; Ben Maïz H; Kheder A
Nephrol Ther; 2011 Nov; 7(6):488-93. PubMed ID: 21376690
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.
Said-Conti V; Amrolia PJ; Gaze MN; Stoneham S; Sebire N; Shroff R; Marks SD
Pediatr Nephrol; 2013 Oct; 28(10):2053-6. PubMed ID: 23743853
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir.
MacGinley R; Bartley PB; Sloots T; Johnson DW
Nephrol Dial Transplant; 2001 Jan; 16(1):197-8. PubMed ID: 11209035
[No Abstract] [Full Text] [Related]
[Next] [New Search]